medigraphic.com
ISSN 2448-8011 (Electronic)
Revista de Divulgación del INSTITUTO DE MEDICINA FORENSE de la UNIVERSIDAD VERACRUZANA

2019, Number 1

<< Back Next >>

Rev Mex Med Forense 2019; 4 (1)

Morbimortality with a packaging technique in prostate surgery

Pérez SLG, Torres HRM, Silva CCS, González JB, Hernández OH

Language: Spanish
References: 18
Page: 24-35
PDF size: 603.59 Kb.


ABSTRACT

Introduction. Prostatic hyperplasia is considered the most common benign tumor in man, causing a rapid evolution in medical and surgical treatment modalities; transurethral endoscopic approach is the goal standard in prostates smaller than 70 grams; above that weight, open surgery is preferred.. Our objective was to determine morbidity and mortality in postoperative patients with prostatic hyperplasia with a new technique of packaging and unpackaging in prostates greater than 70 grams.
Methods. A clinical trial was conducted in 16 patients scheduled for prostatectomy, which were divided into two groups: Group A (n = 7) with the packaging technique and Group B (n = 9) as a control group (without packaging). Post-operative bleeding, number of transfused globular packets, surgical time, concomitant diseases, hospital stay, complications and weight of the gland were measured. The statistical analysis was performed by means of the chi square test for the qualitative variables and the Student's T test.
Results. There was no statistical difference in the T test for the variables of surgical bleeding as well as hemoglobin before and after surgery. The average weight of the prostate in group I was 130.7 grams and in group II 117 grams; greater frequency of comorbid diseases in group 2 was found. There was no surgical mortality.
Conclusions. Transoperative bleeding was more favorable in the control group in terms of lower requirement of globular packages and minor surgical bleeding. No morbidity or postoperative mortality was recorded with the packaging technique. Comorbid diseases had no influence on results.


REFERENCES

  1. Feria BG, Castillejos MRA., Manejo de la hiperplasia prostática benigna, RevMexUrol 2005; 65:55-59.

  2. Fernandez RE, Gomez VF, Alvarez Cl, Ruibal MM, Mosquera RJ and Gonzalez MM. Prevalencia de adenocarcinoma prostático incidental tras adenomectomíasuprapúbica con o sin biopsia prostática previa. Arch EspUrol 2005; 59:31-42

  3. Ross NR, Wenneberg JE, Malenka DJ y cols. Mortality and reoperation after open and transurethral reseccion of the prostate for BPH. N Engl J Med 1985; 320:1120

  4. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978: 15: 340- 345

  5. Barry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J urol 1984; 132:474 - 479

  6. Wein AJ, Kavoussi LR, Novick AC, Partin AW and Peter CA. Campbell – Walsh Urology. 9a ed. 2007, Saunders Elsevier, Philadelphia.

  7. Zalles BM, Carvajal E., Hipertrofia prostática., Rev Paceña MedFam 2006; 3:74-78

  8. Servadio C.,”Is open prostatectomy really obsolete?” Urology 1992; 40:419

  9. Tubaro A, Carter S, Hind A y cols., A prospective study of the safety and efficacy of suprapubictransvesical prostatectomy in patiens with bening prostatic hyperplasia., J Urol., 2001; 166:172

  10. Holtgrewe HL. Surgical management of bening prostatic hyperplasia in 2001: a pause for thought. J Urol 2001; 166:177

  11. Malament M.: Maximal hemostasis in suprapubic prostatectomy. Surg. Gynecol. Obstet 1965; 120:1307

  12. ́Connor V.J., Jr.: An aid for hemostasis in open prostatectomy: Capsular plication. J. Urol 1982; 127:448

  13. Ballesteros SJ, Guzman FA, Lopez BR, Pares PM. Evidencias de la mejoría de los standares de calidad en la cirugía retropúbica por HBP. Arch Esp Urol ,2005; 58:859-866

  14. Saavedra XR, Nossa E, Wilmer A, Plata C, Andrés J, William Q., Prostatectomía Radical despues de cirugía prostática, urolcolomb 2009; 1:71-76

  15. Sach R, Marshall VR. Prostatectomy: its safety in an Australian teaching hospital. Br J Surg. 1977; 64:210-4.

  16. Singh M, Tresidder GC, Blandy JP. The evaluation of transurethral resection for benign enlargement of the prostate. Br J Urol. 1973; 45:93-102.

  17. Koshiba K, Egawa S, Ohori M, Uchida T, Yokoyama E, Shoji K. Does transurethral resection of the prostate pose a risk to life? 22-year outcome. J Urol. 1995; 153:1506-9.

  18. Varkarakis I, Kyriakakis Z, Delis A, Protogerou V,Deliveliotis C. Long-term results of open transvesical prostatectomy from a contemporary series of patients.Urology. 2004; 64:306- 10.




2020     |     www.medigraphic.com